Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain
Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain
Arylamine N-acetyltransferases (NATs) are important in susceptibility to xenobiotic-induced disorders (e.g., drug-induced autoimmune disease, bladder cancer), but their role in endogenous metabolism is yet to be elucidated. The discovery that human NAT1 acts upon p-aminobenzoylgluatamate (p-ABG) to generate p-acetamidobenzoylglutamate (p-AABG), a major urinary metabolite of folic acid, suggests that human NAT1 may play a role in folic acid metabolism and hence in the normal development of the neural tube. In this study we examined the distribution of NAT in neuronal tissue from adult mice and embryos. Immunohistochemical staining of the adult mouse cerebellum revealed NAT2 (the mouse homologue of human NAT1) expression in the cell bodies and dendrites of Purkinje cells and in the neuroglia of the molecular layer. In embryos, NAT2 was detected in developing neuronal tissue on days 9.5, 11.5, and 13.5. It was expressed intensely in the neural tube around the time of closure. The level of expression subsequently declined in the neuroepithelium but increased in glial cells. In addition, NAT2 was detected in the developing heart and gut. These findings demonstrate that the embryo itself expresses an enzyme which is involved in the metabolism of folic acid, so that the role played by both mother and embryo must be considered when examining the role of folic acid in embryonic development. These findings imply that polymorphisms in NAT genes could play a role in determining susceptibility to neural tube defects (NTD) and orofacial clefting, developmental disorders which can be prevented by dietary administration of folic acid.
174-182
Stanley, L.A.
99fadbac-9d58-4cf4-804b-a83f21479113
Copp, A.J.
f6d9f32f-8e7b-46ac-b0cf-f6a63f15c0a9
Pope, J.
b127a4f0-0d56-4b47-b3ab-9d912fed7bda
Rolls, S.
9335f895-a9d3-49a1-a434-66afe2f665ee
Smelt, V.
475ddce4-ae83-4dd5-9bf6-8ab04cd93c93
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
Sim, E.
76b9b428-c005-44d0-972d-edbf3b169443
November 1998
Stanley, L.A.
99fadbac-9d58-4cf4-804b-a83f21479113
Copp, A.J.
f6d9f32f-8e7b-46ac-b0cf-f6a63f15c0a9
Pope, J.
b127a4f0-0d56-4b47-b3ab-9d912fed7bda
Rolls, S.
9335f895-a9d3-49a1-a434-66afe2f665ee
Smelt, V.
475ddce4-ae83-4dd5-9bf6-8ab04cd93c93
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
Sim, E.
76b9b428-c005-44d0-972d-edbf3b169443
Abstract
Arylamine N-acetyltransferases (NATs) are important in susceptibility to xenobiotic-induced disorders (e.g., drug-induced autoimmune disease, bladder cancer), but their role in endogenous metabolism is yet to be elucidated. The discovery that human NAT1 acts upon p-aminobenzoylgluatamate (p-ABG) to generate p-acetamidobenzoylglutamate (p-AABG), a major urinary metabolite of folic acid, suggests that human NAT1 may play a role in folic acid metabolism and hence in the normal development of the neural tube. In this study we examined the distribution of NAT in neuronal tissue from adult mice and embryos. Immunohistochemical staining of the adult mouse cerebellum revealed NAT2 (the mouse homologue of human NAT1) expression in the cell bodies and dendrites of Purkinje cells and in the neuroglia of the molecular layer. In embryos, NAT2 was detected in developing neuronal tissue on days 9.5, 11.5, and 13.5. It was expressed intensely in the neural tube around the time of closure. The level of expression subsequently declined in the neuroepithelium but increased in glial cells. In addition, NAT2 was detected in the developing heart and gut. These findings demonstrate that the embryo itself expresses an enzyme which is involved in the metabolism of folic acid, so that the role played by both mother and embryo must be considered when examining the role of folic acid in embryonic development. These findings imply that polymorphisms in NAT genes could play a role in determining susceptibility to neural tube defects (NTD) and orofacial clefting, developmental disorders which can be prevented by dietary administration of folic acid.
This record has no associated files available for download.
More information
Accepted/In Press date: 18 June 1998
Published date: November 1998
Identifiers
Local EPrints ID: 489614
URI: http://eprints.soton.ac.uk/id/eprint/489614
ISSN: 0040-3709
PURE UUID: cf16705b-1590-4304-ae7f-bf4b850ae0ec
Catalogue record
Date deposited: 29 Apr 2024 16:46
Last modified: 29 Apr 2024 16:46
Export record
Altmetrics
Contributors
Author:
L.A. Stanley
Author:
A.J. Copp
Author:
J. Pope
Author:
S. Rolls
Author:
V. Smelt
Author:
E. Sim
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics